Antibiotic resistance - Problems, progress, and prospects

New England Journal of Medicine

Volumn 371, Issue 19, 2014, Pages 1761-1763

  Nathan, Carl ^a   Cars, Otto ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DISEASE ASSOCIATION; DRUG APPROVAL; ENTEROCOCCUS FAECIUM; HEALTH PROGRAM; HUMAN; KLEBSIELLA PNEUMONIAE; MEDICAL RESEARCH; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA GONORRHOEAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; ARTICLE; BACTERIAL INFECTION; DIFFERENTIAL DIAGNOSIS; DRUG DEVELOPMENT; DRUG INDUSTRY; ECONOMICS; INAPPROPRIATE PRESCRIBING; INFECTION CONTROL; MICROBIOLOGY; VIRUS INFECTION;

BACTERIAL INFECTIONS; COMMUNICABLE DISEASE CONTROL; DIAGNOSIS, DIFFERENTIAL; DRUG APPROVAL; DRUG DISCOVERY; DRUG INDUSTRY; DRUG RESISTANCE, MICROBIAL; HUMANS; INAPPROPRIATE PRESCRIBING; VIRUS DISEASES;

EID: 84908577353     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1408040     Document Type: Article

References (5)

1. Nathan C. Antibiotics at the crossroads. Nature 2004;431:899-902.
2. Cars O. Securing access to effective antibiotics for current and future generations: whose responsibility? Ups J Med Sci 2014;119:209-14.
3. Nathan C. Fresh approaches to anti-infective therapies. Sci Transl Med 2012;4:140sr2.
4. Nathan C. Aligning pharmaceutical innovation with medical need. Nat Med 2007;13:304-8.
5. So AD, Ruiz-Esparza Q, Gupta N, Cars O. 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards. BMJ 2012;344:e1782.